Kuo-Pyng Shen , Rong-Jyh Lin , Chiu-Yin Lin , Lien-Chai Chiang , Wen-Ter Lai , Chang-Jenq Cheng , Ing-Jun Chen , Bin-Nan Wu
{"title":"A unique xanthine derivative KMCP-98 with activation of adenosine receptor subtypes","authors":"Kuo-Pyng Shen , Rong-Jyh Lin , Chiu-Yin Lin , Lien-Chai Chiang , Wen-Ter Lai , Chang-Jenq Cheng , Ing-Jun Chen , Bin-Nan Wu","doi":"10.1016/S0306-3623(01)00090-8","DOIUrl":null,"url":null,"abstract":"<div><p>KMCP-98 is a newly synthesized adenosine receptor agonist by alkylation at the 7-position of the xanthines nucleus. We first investigated the pharmacological activities of KMCP-98 under in vivo and in vitro conditions. Acute intravenous injection of KMCP-98 (1.0, 2.0 and 3.0 mg/kg) produced a temporary fall in blood pressure and heart rate, followed by a sustained fall in heart rate in pentobarbital-anesthetized Wistar rats. The hypotensive and bradycardiac responses were inhibited by pretreatment with an A<sub>1</sub> adenosine receptor antagonist 8-phenyltheophylline (8-PT, 0.5 mg/kg). Both KMCP-98 and adenosine (0.3–100 μM) produced negative inotropic activitity in isolated guinea pig left atria. The negative inotropic activity of KMCP-98 was significantly blocked by pretreatment with A<sub>1</sub> receptor antagonists 8-PT (10 μM) and xanthine amine congener (XAC, 10 μM), a nonselective adenosine antagonist theophylline (10 μM), a K<sup>+</sup> channel blocker tetraethylammonium (TEA, 10 mM) and a K<sub>ATP</sub> channel blocker glibenclamide (1 μM). KMCP-98 (0.03–30 μM) produced concentration-dependent relaxations in carbachol (1 μM) precontracted guinea pig tracheal smooth muscle. The trachea relaxant response of KMCP-98 was markedly inhibited by A<sub>2</sub>, A<sub>2a</sub> and A<sub>2b</sub> adenosine receptor antagonists 3,7-dimethyl-1-propargylxanthine (DMPX, 10 μM), 8-(3-chlorostyryl)caffeine (CSC, 10 μM) and alloxazine (10 μM), respectively, the nitric oxide synthase (NOS) inhibitor <span>l</span>-NAME (100 μM) and also by TEA and glibenclamide. In addition, KMCP-98 (0.03–30 μM) elicited relaxant response in norepinephrine (3 μM) precontracted rat thoracic aorta in a concentration-dependent manner. The thoracic aorta relaxant response of KMCP-98 was also significantly inhibited by DMPX, CSC, alloxazine, <span>l</span>-NAME, TEA and glibenclamide. Furthermore, the binding characteristics of KMCP-98, adenosine and 5′-<em>N</em>-ethylcarboxaminoadenosine (NECA) were evaluated in [<sup>3</sup>H]DPCPX and [<sup>3</sup>H]CGS 21680 binding to rat cortex and striatum, respectively. The <em>K</em><sub>i</sub> values of KMCP-98 for predominate A<sub>1</sub> and A<sub>2</sub> adenosine receptor sites were 3908±952 and 158±10 nM, respectively. In conclusion, KMCP-98 was found to be a xanthine-based adenosine receptor agonist associated cardiac depression, tracheal and aortic smooth muscle relaxations.</p></div>","PeriodicalId":12607,"journal":{"name":"General Pharmacology-the Vascular System","volume":"35 1","pages":"Pages 47-57"},"PeriodicalIF":0.0000,"publicationDate":"2000-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0306-3623(01)00090-8","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"General Pharmacology-the Vascular System","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0306362301000908","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
KMCP-98 is a newly synthesized adenosine receptor agonist by alkylation at the 7-position of the xanthines nucleus. We first investigated the pharmacological activities of KMCP-98 under in vivo and in vitro conditions. Acute intravenous injection of KMCP-98 (1.0, 2.0 and 3.0 mg/kg) produced a temporary fall in blood pressure and heart rate, followed by a sustained fall in heart rate in pentobarbital-anesthetized Wistar rats. The hypotensive and bradycardiac responses were inhibited by pretreatment with an A1 adenosine receptor antagonist 8-phenyltheophylline (8-PT, 0.5 mg/kg). Both KMCP-98 and adenosine (0.3–100 μM) produced negative inotropic activitity in isolated guinea pig left atria. The negative inotropic activity of KMCP-98 was significantly blocked by pretreatment with A1 receptor antagonists 8-PT (10 μM) and xanthine amine congener (XAC, 10 μM), a nonselective adenosine antagonist theophylline (10 μM), a K+ channel blocker tetraethylammonium (TEA, 10 mM) and a KATP channel blocker glibenclamide (1 μM). KMCP-98 (0.03–30 μM) produced concentration-dependent relaxations in carbachol (1 μM) precontracted guinea pig tracheal smooth muscle. The trachea relaxant response of KMCP-98 was markedly inhibited by A2, A2a and A2b adenosine receptor antagonists 3,7-dimethyl-1-propargylxanthine (DMPX, 10 μM), 8-(3-chlorostyryl)caffeine (CSC, 10 μM) and alloxazine (10 μM), respectively, the nitric oxide synthase (NOS) inhibitor l-NAME (100 μM) and also by TEA and glibenclamide. In addition, KMCP-98 (0.03–30 μM) elicited relaxant response in norepinephrine (3 μM) precontracted rat thoracic aorta in a concentration-dependent manner. The thoracic aorta relaxant response of KMCP-98 was also significantly inhibited by DMPX, CSC, alloxazine, l-NAME, TEA and glibenclamide. Furthermore, the binding characteristics of KMCP-98, adenosine and 5′-N-ethylcarboxaminoadenosine (NECA) were evaluated in [3H]DPCPX and [3H]CGS 21680 binding to rat cortex and striatum, respectively. The Ki values of KMCP-98 for predominate A1 and A2 adenosine receptor sites were 3908±952 and 158±10 nM, respectively. In conclusion, KMCP-98 was found to be a xanthine-based adenosine receptor agonist associated cardiac depression, tracheal and aortic smooth muscle relaxations.